Molecularly Stratified Treatment Options in Primary Refractory DLBCL/HGBL with MYC and BCL2 or BCL6 Rearrangements (HGBL, NOS with MYC/BCL6)

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
Molecularly Stratified Treatment Options in Primary Refractory DLBCL/HGBL with MYC and BCL2 or BCL6 Rearrangements (HGBL, NOS with MYC/BCL6) ; volume:18 ; number:5 ; day:24 ; month:7 ; year:2023 ; pages:749-765 ; date:9.2023
Targeted oncology ; 18, Heft 5 (24.7.2023), 749-765, 9.2023

Creator
Witte, Hanno M.
Riedl, Jörg
Künstner, Axel
Fähnrich, Anke
Ketzer, Julius
Fliedner, Stephanie M. J.
Reimer, Niklas
Bernard, Veronica
Bubnoff, Nikolas von
Merz, Hartmut
Busch, Hauke
Feller, Alfred
Gebauer, Niklas
Contributor
SpringerLink (Online service)

DOI
10.1007/s11523-023-00983-5
URN
urn:nbn:de:101:1-2023121213084721003269
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:36 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Witte, Hanno M.
  • Riedl, Jörg
  • Künstner, Axel
  • Fähnrich, Anke
  • Ketzer, Julius
  • Fliedner, Stephanie M. J.
  • Reimer, Niklas
  • Bernard, Veronica
  • Bubnoff, Nikolas von
  • Merz, Hartmut
  • Busch, Hauke
  • Feller, Alfred
  • Gebauer, Niklas
  • SpringerLink (Online service)

Other Objects (12)

Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes

Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes

Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors

Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors

Aberrant patterns of PET response during treatment for DLBCL patients with MYC gene rearrangements

Aberrant patterns of PET response during treatment for DLBCL patients with MYC gene rearrangements

High-grade B-cell lymphoma with MYC and BCL2 rearrangements arising in a composite lymphoma

High-grade B-cell lymphoma with MYC and BCL2 rearrangements arising in a composite lymphoma

Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients

Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients

B-lymphoblastic leukemia/lymphoma with MYC and BCL2 gene rearrangements shows evidence for clonal evolution and mitotic recombination

B-lymphoblastic leukemia/lymphoma with MYC and BCL2 gene rearrangements shows evidence for clonal evolution and mitotic recombination

Molecular characterization of a rare case of high-grade B-cell lymphoma with MYC, BCL2, BCL6, and CCND1 rearrangements

Molecular characterization of a rare case of high-grade B-cell lymphoma with MYC, BCL2, BCL6, and CCND1 rearrangements

Molecularly distinct models of zebrafish Myc-induced B cell leukemia

Molecularly distinct models of zebrafish Myc-induced B cell leukemia

MYC

Graffiti | Streetart

MYC

MYC

Graffiti | Streetart

MYC

MYC

Graffiti | Streetart

MYC

Targeted inhibition of DHODH is synergistic with BCL2 blockade in HGBCL with concurrent MYC and BCL2 rearrangement

Targeted inhibition of DHODH is synergistic with BCL2 blockade in HGBCL with concurrent MYC and BCL2 rearrangement

Related objects